France's COVID-19 diagnostics market will see a considerable decline of 27.5% during the forecast period. COVID-19 testing has emerged rapidly in France owing to the surge in the daily COVID-19 incidences and government initiatives for free testing of coronavirus. On March 25, 2020, France Government declared that it would roll out a $4.33 billion liquidity support plan for start-ups amid coronavirus pandemics. On June 10, 2020, the government declared that it would propose a stimulus package of $51 million to boost the country’s plunging economy amid a coronavirus outbreak. This package is intended to revive the economy as the French minister has predicted the plunge and wave of bankruptcies in the French economy which could last up to 2021.
Browse the full report description France COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-User (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026 at https://www.omrglobal.com/industry-reports/france-covid-19-diagnostics-market
On March 18, 2020, France introduced an online test for the evaluation of coronavirus symptoms and a guide regarding steps needs to be taken. This test was approved by the French health ministry, available on the website maladiecoronavirus.fr. On July 25, 2020, French authorities declared that they are making available COVID-19 tests free of charge without prescription, coupled with the rising COVID-19 cases in the country. The country closely reporting a noticeable increase in the COVID-19 cases after the lifting of lockdown measures. Under government orders, PCR nasal swab tests will be freely available on demand. This initiative will further extend the testing capacity of the country.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2020-2026 |
|
Segments Covered |
By Type, By Technology Type, By Sample Type, and By End-Users |
|
Key Companies Profiled |
bioMérieux SA, GeneStore France SAS, Eurobio
Scientific SA, Sanofi SA, and NG Biotech |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID
o Most affected segment
o Recommendations
France COVID-19 Diagnostics Market – Segmentation
By Type
By Technology Type
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
By Sample Type
By End-Users
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/france-covid-19-diagnostics-market